{
  "NCT04280705": {
    "nct_id": "NCT04280705",
    "brief_title": "Adaptive COVID-19 Treatment Trial (ACTT)",
    "official_title": "A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults",
    "status": "COMPLETED",
    "phase": "PHASE3",
    "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)",
    "conditions": [
      "COVID-19"
    ],
    "interventions": [
      "Remdesivir",
      "Placebo"
    ],
    "enrollment": 1062,
    "start_date": "2020-02-21",
    "completion_date": "2020-04-19",
    "eligibility": {
      "minimum_age": "18 Years",
      "sex": "ALL",
      "healthy_volunteers": "No"
    }
  },
  "NCT06524388": {
    "nct_id": "NCT06524388",
    "brief_title": "Study of Novel Cancer Immunotherapy",
    "official_title": "A Phase 2 Randomized Study of Novel Checkpoint Inhibitor Combination in Advanced Solid Tumors",
    "status": "RECRUITING",
    "phase": "PHASE2",
    "sponsor": "Example Pharmaceuticals",
    "conditions": [
      "Solid Tumors",
      "Advanced Cancer"
    ],
    "interventions": [
      "Drug A",
      "Drug B",
      "Placebo"
    ],
    "enrollment": 450,
    "start_date": "2024-01-15",
    "eligibility": {
      "minimum_age": "18 Years",
      "maximum_age": "75 Years",
      "sex": "ALL",
      "healthy_volunteers": "No"
    }
  }
}